Israel-based Trendlines, which is listed on the SGX, will receive net proceeds of US$15.8 million for its 26.9% stake.
The Trendlines Group has divested its stake in one of its portfolio companies focusing on orthopedics to Synthes, a subsidiary of Johnson & Johnson.
The portfolio company, OrthoSpin, is sold to the US healthcare giant for US$79.5 million.
